Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials. - Wikidata - thesis-toulmin - TriplyDB

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

http://www.wikidata.org/entity/Q33586021

about

Response Assessment in Neuro-Oncology Clinical Trials.Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.Longitudinal Patterns in Clinical and Imaging Measurements Predict Residual Survival in Glioblastoma Patients

P2860

Q45945655-D7462933-C78D-4E94-A3C0-C5C5C7D4AE4E Q46860353-EEF53D0B-7DD3-47F9-AFA2-6EEC855CE402 Q47976126-0B1382AC-FFFF-4A9F-B6A8-D5B410C95E73 Q48155295-C4893819-A4AA-4D11-8862-096BAFB53B86 Q55457095-26560A51-2D3E-4A0A-A290-22E4AFBDDBBF Q58695362-F2FC9A44-6E28-4D65-BD9A-636685B4A574

P2860

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

http://www.wikidata.org/entity/Q33586021

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@ast

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@en

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@nl

type

label

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@ast

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@en

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@nl

prefLabel

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@ast

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@en

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@nl

P1433

Q33586021-6C657854-2E12-4A4E-A8CD-9EBFF2A41724

P1476

Q33586021-315EA1E3-7A6E-44DD-BB5A-8F437BB61DB8

P2093

Q33586021-389EA113-2946-434F-89F4-8B9A169693C4

Q33586021-D32EA508-06C3-44A9-B591-631138686988

Q33586021-F254C777-1426-4A05-93EC-40FBA777BB18

P275

Q33586021-7D664459-37E4-4EBB-B9A1-81C84E167526

P2860

Q33586021-00835360-5757-4BFC-8897-3675D30B006E

Q33586021-022B6684-CF9C-49EC-B52D-A90C9631F98D

Q33586021-06C809D7-20BA-4AC2-90EE-096737A9C939

Q33586021-07EEFB92-33A5-431C-8E62-736066653F15

Q33586021-09E616BA-1541-449E-9043-AB2E31303C0B

Q33586021-0CF1325E-09F5-45E4-B37B-91B663CEE373

Q33586021-0DE7F36A-544B-4573-B334-DC7DE8007279

Q33586021-0EDCE64C-EA58-477E-B8B3-3250309DA876

Q33586021-11583BF4-90A5-433C-8573-56F2D4487499

Q33586021-1272CF06-FF14-438E-869E-4309A8A2645E

P2888

Q33586021-FEB4B467-C134-4EA6-B863-5E22BF025924

P304

Q33586021-362AC7E6-150C-498D-BC52-DED57E4225A2

P31

Q33586021-360309CD-12D0-4A87-B5C2-B932EE27FEE3

Q33586021-9E9DE3D1-D498-43F3-9124-28C40F04A961

P356

Q33586021-B31E86EB-D1D4-4DAF-A60F-F7B904329488

P433

Q33586021-E36FD0C4-29BA-41EC-87E9-D1DED849A9AF

P478

Q33586021-17F32E05-3C54-4D38-B596-31CCD2A6C6E6

P5008

Q33586021-FEC26FFB-7872-4408-A4D1-A371E3B99892

P577

Q33586021-5110E2C3-483B-4CFE-AA87-AEC324663A06

Q33586021-F97C2D6B-A349-4B24-92AC-A20CAF13AE7D

P698

Q33586021-AE2E8CA8-38E1-43A7-B038-7A496854C7D8

P921

Q33586021-180F7912-F85C-4D85-BA51-E9ED8391FB37

Q33586021-9BA46567-6B16-49C5-9CC0-7105B5FBE438

P932

Q33586021-A3EB7EB3-0942-4678-8025-8CAF8B62BCA0

P356

S13311-016-0507-6

P1433

Neurotherapeutics

P1476

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

@en

P2093

Benjamin M Ellingson

http://www.w3.org/2001/XMLSchema#string

Patrick Y Wen

http://www.w3.org/2001/XMLSchema#string

Timothy F Cloughesy

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Role of angiogenesis in tumor growth and metastasis

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Reporting results of cancer treatment

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

P2888

s13311-016-0507-6

P304

307-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-016-0507-6

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28108885

http://www.w3.org/2001/XMLSchema#string

P921

P932

5398984

http://www.w3.org/2001/XMLSchema#string